Attie Kenneth 4
4 · Altus Pharmaceuticals Inc. · Filed Jan 29, 2009
Insider Transaction Report
Form 4
Attie Kenneth
VP, Clinical Dev & Med Affairs
Transactions
- Award
Common Stock Option (right to buy)
2009-01-27+250,000→ 250,000 totalExercise: $0.22Exp: 2019-01-27→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]All of such options have a term of ten years vesting over four years, with 1/16th of the options vesting every three months. All of such options become exercisable as they vest.